BIO – bio-rad laboratories, inc. class a (US:NASDAQ)

News

Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference
Metagenomic Market Research 2025-2029 - Global Market Analysis and Forecasts with Executive and Consultant Guides - A Game Changer in Diagnostics? New Technology Changes Viewpoint on Infections [Yahoo! Finance]
Food Safety Testing Market Report (by Contaminants, Pathogens, Types of Food Tested, Technology/Method, Regional Analysis) 2024-2032 [Yahoo! Finance]
Bioprocess Validation Market to hit USD 1.03 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Royal Bank of Canada from $369.00 to $481.00. They now have an "outperform" rating on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com